Thrombosis Trials in Boston, United States
Conditions / Thrombosis / Boston, United States
Thrombosis has been the subject of sustained clinical investigation across multiple research sites.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06434207 | Extracellular Vesicle Micro RNA Profiling in Congenital Heart Disease: Fetal-Maternal Regulation in Neonatal Thrombosis | RECRUITING | — |
| NCT02846532 | Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure | COMPLETED | PHASE3 |
| NCT00039858 | Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin | COMPLETED | PHASE4 |
| NCT02064439 | Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism) | COMPLETED | PHASE3 |
| NCT06676904 | Neonatal Platelet Transfusion Threshold Trial | RECRUITING | NA |
| NCT03830320 | Positron Emission Tomography (PET) Imaging of Thrombosis | RECRUITING | PHASE1 |
| NCT02981472 | A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation | COMPLETED | PHASE2 |
| NCT02671461 | Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or Mini Strokes | COMPLETED | PHASE2 |
| NCT00320255 | A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer | COMPLETED | PHASE2 |
| NCT04398628 | ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders | RECRUITING | — |